<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02316184</url>
  </required_header>
  <id_info>
    <org_study_id>AA023726</org_study_id>
    <nct_id>NCT02316184</nct_id>
  </id_info>
  <brief_title>Comparing Brief Alcohol Interventions For HIV-HCV Co-infected Persons</brief_title>
  <acronym>REACH</acronym>
  <official_title>Comparing Brief Alcohol Interventions For HIV-HCV Co-infected Persons</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Butler Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Butler Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Two types of brief intervention, Brief Advice (BA) and Motivational Interviewing (MI), have&#xD;
      been shown to be efficacious in reducing drinking in non-HIV samples. Our goal is to&#xD;
      determine whether offering counseling beyond Brief Advice, namely MI, has greater alcohol&#xD;
      reduction effects. In the proposed randomized trial, all 300 HIV-HCV co-infected participants&#xD;
      will receive BA delivered by their HIV PCP during a regular HIV visit and will then be&#xD;
      randomized to either a 30-minute Motivational Interviewing Intervention with a Behavioral&#xD;
      Counselor (MI) or to HIV clinic treatment-as-usual. After this initial meeting, drinking&#xD;
      &quot;check-in&quot; (MI or BA) sessions will then be provided telephonically every three months for 18&#xD;
      months, with a final assessment at 24 months. Our primary outcome is drinks per week.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two types of brief intervention, Brief Advice (BA) and Motivational Interviewing (MI), have&#xD;
      been shown to be efficacious in reducing drinking in non-HIV samples. Our goal is to&#xD;
      determine whether offering counseling beyond Brief Advice, namely MI, has greater alcohol&#xD;
      reduction effects. In the proposed randomized trial, all 300 HIV-HCV co-infected participants&#xD;
      will receive BA delivered by their HIV PCP during a regular HIV visit and will then be&#xD;
      randomized to either a 30-minute Motivational Interviewing Intervention with a Behavioral&#xD;
      Counselor (MI) or to HIV clinic treatment-as-usual. After this initial meeting, drinking&#xD;
      &quot;check-in&quot; (MI or BA) sessions will then be provided telephonically every three months for 18&#xD;
      months. Research assessments will also be done every three months, with a final assessment at&#xD;
      24 months. Our primary outcome is drinks per week.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Actual">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alcohol Use questionnaire</measure>
    <time_frame>up to 24 months</time_frame>
    <description>participants will be asked how many drinks/week they have</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>HIV</condition>
  <condition>Hepatitis C</condition>
  <arm_group>
    <arm_group_label>Brief Advice</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants in this arm will receive brief advice about alcohol use. Sessions will occur at the baseline interview and every three months for 18 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this arm will receive a talking intervention designed to explore their interest in reducing/eliminating alcohol use. Sessions will occur at the baseline interview and every three months for 18 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motivational Interviewing</intervention_name>
    <description>Motivational Interviewing is a client-centered method of exploring individual's interest in making behavioral changes. In this study, the targeted behavior is alcohol use.</description>
    <arm_group_label>MI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Brief Advice</intervention_name>
    <arm_group_label>Brief Advice</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  HIV+&#xD;
&#xD;
          -  HCV RNA positive&#xD;
&#xD;
          -  consuming on average at least 4 alcoholic drinks per week in the last month&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  current, severe psychiatric symptoms requiring immediate clinical attention (e.g.,&#xD;
             suicidal ideation, current mania, psychosis)&#xD;
&#xD;
          -  inability to understand English&#xD;
&#xD;
          -  cognitive impairment severe enough to interfere with ability to actively participate&#xD;
&#xD;
          -  hepatocellular carcinoma or life expectancy less than 24 months&#xD;
&#xD;
          -  plan to move from Providence area in the next 24 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Stein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Butler Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Butler Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miriam Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 10, 2014</study_first_submitted>
  <study_first_submitted_qc>December 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2014</study_first_posted>
  <last_update_submitted>March 19, 2021</last_update_submitted>
  <last_update_submitted_qc>March 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Butler Hospital</investigator_affiliation>
    <investigator_full_name>Michael Stein, MD</investigator_full_name>
    <investigator_title>Principal Investigator (MPI)</investigator_title>
  </responsible_party>
  <keyword>Alcohol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis C</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

